| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010337209 |
| P356 | DOI | 10.1038/KI.2013.82 |
| P698 | PubMed publication ID | 23486519 |
| P5875 | ResearchGate publication ID | 236042797 |
| P2093 | author name string | Weidong Wang | |
| Dapeng Wang | |||
| Nan Shen | |||
| Zhe Feng | |||
| Hua Xie | |||
| Taihua Wu | |||
| Hongli Lin | |||
| Jianing Zhang | |||
| P2860 | cites work | Crystal structure of mammalian alpha1,6-fucosyltransferase, FUT8 | Q24337064 |
| TGF-β - an excellent servant but a bad master | Q27025590 | ||
| Transforming growth factor-beta regulation of immune responses | Q28303115 | ||
| Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling | Q28582397 | ||
| Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice | Q28585434 | ||
| Glycosylation in cellular mechanisms of health and disease | Q29617310 | ||
| Fight-or-flight: murine unilateral ureteral obstruction causes extensive proximal tubular degeneration, collecting duct dilatation, and minimal fibrosis | Q30418407 | ||
| Simultaneous analysis of proteome, phospho- and glycoproteome of rat kidney tissue with electrostatic repulsion hydrophilic interaction chromatography | Q31001440 | ||
| Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCC | Q33307815 | ||
| Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS. | Q33399573 | ||
| Detection of hepatocellular carcinoma using glycomic analysis | Q33410061 | ||
| Protein modifications as potential biomarkers in breast cancer. | Q33586407 | ||
| Specificity, diversity, and regulation in TGF-beta superfamily signaling. | Q33792305 | ||
| Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity | Q33978189 | ||
| Inhibition of p38 mitogen-activated protein kinase and transforming growth factor-beta1/Smad signaling pathways modulates the development of fibrosis in adriamycin-induced nephropathy. | Q35607297 | ||
| Analysis of expression and posttranslational modification of proteins during hypoxia | Q35651190 | ||
| Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse | Q35842105 | ||
| Transforming growth factor-beta and Smad signalling in kidney diseases. | Q36037583 | ||
| Obstructive nephropathy: insights from genetically engineered animals | Q36232250 | ||
| The structural basis of TGF-beta, bone morphogenetic protein, and activin ligand binding | Q36555325 | ||
| Phenotype changes of Fut8 knockout mouse: core fucosylation is crucial for the function of growth factor receptor(s). | Q36667067 | ||
| TGFbeta signalling in control of T-cell-mediated self-reactivity | Q36831664 | ||
| TGF-beta in renal injury and disease | Q36833398 | ||
| Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations | Q36921222 | ||
| Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction | Q36991087 | ||
| Functional roles of N-glycans in cell signaling and cell adhesion in cancer | Q37168602 | ||
| Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery | Q37482129 | ||
| Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. | Q37512817 | ||
| Regulation of TGF-beta signalling by protein phosphatases | Q37779572 | ||
| Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells | Q39608719 | ||
| Role of E-cadherin N-glycosylation profile in a mammary tumor model | Q39892493 | ||
| Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis | Q40446335 | ||
| Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. | Q40456120 | ||
| Therapy with antisense TGF-beta1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice | Q40888786 | ||
| Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease | Q41078715 | ||
| Biology of TGF-beta in knockout and transgenic mouse models | Q41469668 | ||
| TGF-beta in kidney fibrosis: a target for gene therapy | Q41469693 | ||
| Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts. | Q45249894 | ||
| Suppression of cyclosporine a nephrotoxicity in vivo by transforming growth factor beta receptor-immunoglobulin G chimeric protein | Q47418922 | ||
| Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro. | Q52619754 | ||
| The fucosylation index of alpha-fetoprotein and its usefulness in the early diagnosis of hepatocellular carcinoma | Q69015454 | ||
| Stachybotrydial, a potent inhibitor of fucosyltransferase and sialyltransferase | Q81729837 | ||
| Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo | Q83897434 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 64-77 | |
| P577 | publication date | 2013-03-13 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Inhibition of TGF-β1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis | |
| P478 | volume | 84 |
| Q55617732 | A Crude 1-DNJ Extract from Home Made Bombyx Batryticatus Inhibits Diabetic Cardiomyopathy-Associated Fibrosis in db/db Mice and Reduces Protein N-Glycosylation Levels. |
| Q90584370 | Acetyl-11-keto-β-boswellic acid ameliorates renal interstitial fibrosis via Klotho/TGF-β/Smad signalling pathway |
| Q92015345 | Acupuncture attenuates renal interstitial fibrosis via the TGF‑β/Smad pathway |
| Q39685653 | Arg tyrosine kinase modulates TGF-β1 production in human renal tubular cells under high-glucose conditions |
| Q41098131 | Blocking Posttranslational Core Fucosylation Ameliorates Rat Peritoneal Mesothelial Cell Epithelial-Mesenchymal Transition. |
| Q47264485 | Experimental Inhibition of Periostin Attenuates Kidney Fibrosis |
| Q55032489 | Galangin inhibits hypertrophic scar formation via ALK5/Smad2/3 signaling pathway. |
| Q45096217 | Inhibiting post-translational core fucosylation protects against albumin-induced proximal tubular epithelial cell injury |
| Q89967666 | Metabolic Coordination of Pericyte Phenotypes: Therapeutic Implications |
| Q41645569 | MicroRNA-196a/b Mitigate Renal Fibrosis by Targeting TGF-β Receptor 2 |
| Q50868609 | New wrinkles in old receptors: core fucosylation is yet another target to inhibit TGF-β signaling. |
| Q47112638 | Novel Mechanism of the Pericyte-Myofibroblast Transition in Renal Interstitial Fibrosis: Core Fucosylation Regulation. |
| Q37210162 | Protective Effects of Berberine on Renal Injury in Streptozotocin (STZ)-Induced Diabetic Mice |
| Q47878548 | Silencing of SOCS-1 and SOCS-3 suppresses renal interstitial fibrosis by alleviating renal tubular damage in a rat model of hydronephrosis |
| Q42175254 | Silencing of activin receptor-like kinase 7 alleviates aortic stiffness in type 2 diabetic rats |
| Q26851198 | TGF-β/Smad signaling in renal fibrosis |
| Q39240506 | The bittersweet taste of tubulo-interstitial glycans |
| Q26775058 | The molecular mechanisms of hemodialysis vascular access failure |
| Q33769240 | The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats |
| Q48681668 | WITHDRAWN: Protective role of activin receptor-like kinase 7 gene silencing in renal fibrosis |
| Q87523228 | siRNA-targeting transforming growth factor-β type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue |
Search more.